Screener
Immunome IMNM Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Immunome’s reported figures.
Based on trailing twelve months.
The source filing: Immunome’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
FAQ
- What is Immunome's operating margin?
- Immunome (IMNM) reported operating margin of -5,947.9% in Q1 2026.
- How has Immunome's operating margin changed year-over-year?
- Immunome's operating margin decreased by 198.2% year-over-year, from -1,994.3% to -5,947.9%.
- What is the long-term trend for Immunome's operating margin?
- Over 2 years (2023 to 2025), Immunome's operating margin has grown at a 103.3% compound annual growth rate (CAGR), from -781.4% to -3,228.8%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Immunome's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude